CompletedNot Applicable

Early Lung Cancer Diagnosis in HIV Infected Population With an Important Smoking History With Low Dose CT: a Pilot Study

France450 participantsStarted 2011-02

Plain-language summary

Early Lung Cancer diagnosis in a HIV-infected population with an important smoking history with low-dose CT: a pilot study: the HIV-CHEST study Objectives The main objective of this study is to evaluate the prevalence of lung cancers detected by low-dose computed tomography (CT) in a HIV-infected population with an important smoking history. Other objectives are (1) the evaluation of the types of lung cancers in this population, as well as (2) the staging of non small cell lung cancers, (3) the description of risk factors for all lung cancers, if they are numerous enough, and (4) the number of complications of diagnosis procedures during the study.

Who can participate

Age range40 Years – 85 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Age ≥ 40 years * able to give written consent * HIV positive serology * Covered by French Social Security * Nadir L TCD4 \< 350/µl * Rate of LTCD4 \> 100/µl at inclusion * Addiction to smoking \> 20 packages years, active person or deprived since \< 3 years Exclusion Criteria: * patients who suffered from comorbidity * unaffiliated to the social healthy security french system * Presence of an evolutionary cancer * any evolutionary pathology classifying AIDS * Pregnancy * Recent lung infection (\< 2 months) * Be under protection (saving) of justice

What they're measuring

the prevalence of lung cancers detected by lowdose computed tomography

Timeframe: Month 0

Trial details

NCT IDNCT01207986

SponsorANRS, Emerging Infectious Diseases

Sponsor typeOTHER_GOV

Study typeINTERVENTIONAL

Primary completion2012-06

View on ClinicalTrials.gov More Hiv Infection trials